Evidence map›Paper›PMID 40225407›Full record

ArticleOphthalmology science

Enhanced Macular Telangiectasia Type 2 Detection: Leveraging Self-Supervised Learning and Ensemble Models.

Shahrzad Gholami, Lea Scheppke, Meghana Kshirsagar, Yue Wu, Rahul Dodhia, Roberto Bonelli, Irene Leung, Ferenc B Sallo, Alyson Muldrew, Catherine Jamison and 6 more

Abstract read
In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Table-based language models for ophthalmology assessment in the emergency department.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shahrzad GholamiAI for Good Research Lab, Microsoft, Redmond, Washington.
Lea ScheppkeThe Lowy Medical Research Institute, La Jolla, California.
Meghana KshirsagarAI for Good Research Lab, Microsoft, Redmond, Washington.
Yue WuDepartment of Ophthalmology, University of Washington, Seattle, Washington.
Rahul DodhiaAI for Good Research Lab, Microsoft, Redmond, Washington.
Roberto BonelliThe Lowy Medical Research Institute, La Jolla, California.
Irene LeungMoorfields Eye Hosptial NHS Foundation Trust, London, United Kingdom.
Ferenc B SalloDepartment of Ophthalmology, Jules Gonin Eye Hospital, University of Lausanna, Lausanna, Switzerland.
Alyson MuldrewCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Catherine JamisonCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Tunde PetoCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Juan Lavista FerresAI for Good Research Lab, Microsoft, Redmond, Washington.
William B WeeksAI for Good Research Lab, Microsoft, Redmond, Washington.
Martin FriedlanderThe Lowy Medical Research Institute, La Jolla, California.
Aaron Y LeeDepartment of Ophthalmology, University of Washington, Seattle, Washington.
Lowy Medical Research Institute

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate an ensemble-based approach utilizing deep learning models for accurate and interpretable detection of macular telangiectasia (MacTel) type 2 on OCT imaging. Design: Retrospective analysis of OCT scans, model development, and assessment. Participants: A total of 5200 OCT images from participants in the MacTel Registry conducted by the Lowy Medical Research Institute and from the University of Washington (780 MacTel patients and 1900 non-MacTel patients). Methods Intervention or Testing: We trained multiple individual MacTel vs. non-MacTel classification models using traditional supervised learning and self-supervised learning (SSL) and ensembled them using average weighting methods. We investigated diverse methodologies for constructing the ensemble, including varied architectural configurations and learning paradigms of individual models, and manipulating the amount of labeled data accessible for training. Model performance was compared against human expert graders on held-out test set data. Model interpretability was investigated using gradient-weighted class activation maps (Grad-CAM) visualization and by evaluating interrater agreement. Main Outcome Measures: For model performance, area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), accuracy, sensitivity, and specificity were reported. For interpretability, interrater agreements and Grad-CAM visualization results were evaluated. Results: Despite access to only 419 OCT volumes, including 185 MacTel patients within the 10% labeled training dataset, the ensemble model demonstrated a performance level (AUROC 0.972 [95% confidence interval (CI), 0.971-0.973], AUPRC 0.967 [95% CI, 0.965-0.969], accuracy 91.7%, sensitivity 0.905, and specificity 0.925) comparable to the human experts ensemble (AUROC 0.977 [95% CI, 0.975-0.978], AUPRC 0.987 [95% CI, 0.986-0.987], accuracy 96.8%, sensitivity 0.929, and specificity 1) on a test set of 500 patients. The individual models did not achieve the same performance levels when evaluated separately. Conclusions: Even with limited data, combining SSL with ensemble approaches improved MacTel classification accuracy and interpretation compared to the individual models. Self-supervised learning captures meaningful representations from unlabeled data, a key benefit in the setting of limited data such as with rare diseases. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Deep learningEnsemble modelsMacular telangiectasia type 2OCT imagingSelf-supervised learning

Identifiers

PMID40225407
PMCPMC11987621

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.